Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Feb 25 | SGMO | Sangamo Therapeutics, INC | FTAX | 12,354 | $0.47 | $5.8K | -1.9% | Open the original filing on SEC.gov |
| Feb 24 | SGMO | Sangamo Therapeutics, INC | FTAX | 1,650 | $0.4725 | $780 | -0.3% | Open the original filing on SEC.gov |
| Jan 22 | SGMO | Sangamo Therapeutics, INC | FTAX | 36,676 | $0.3985 | $14.6K | -5.2% | Open the original filing on SEC.gov |
| Nov 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 2,035 | $0.4166 | $848 | -0.3% | Open the original filing on SEC.gov |
| Oct 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 44,122 | $0.66 | $29.1K | -5.9% | Open the original filing on SEC.gov |
| Aug 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 1,434 | $0.5863 | $841 | -0.2% | Open the original filing on SEC.gov |
| Jul 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 31,866 | $0.4798 | $15.3K | -4.1% | Open the original filing on SEC.gov |
| May 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 1,433 | $0.4733 | $678 | -0.2% | Open the original filing on SEC.gov |
| Apr 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 31,866 | $0.7763 | $24.7K | -3.9% | Open the original filing on SEC.gov |